149
Participants
Start Date
April 11, 2020
Primary Completion Date
February 7, 2022
Study Completion Date
February 7, 2022
TJ003234
patients receive a single infusion
Placebo
patients receive a single infusion
Georgetown University Hospital, Washington D.C.
The GW Medical Faculty Associates, Washington D.C.
University of Miami, Miami
University of Mississippi Medical Center, Jackson
Indiana University Health, Indianapolis
OSF Healthcare Saint Francis Medical Center, Peoria
Medpharmics, LLC, Metairie
Ochsner Medical Center, New Orleans
University of Arkansas, Little Rock
Houston Methodist Hospital, Houston
UNM Hospitals, Albuquerque
University Medical Center of Southern Nevada, Las Vegas
Olive View-UCLA Medical Center, Sylmar
Brigham and Women's Hospital, Boston
Lead Sponsor
I-Mab Biopharma US Limited
INDUSTRY